Pennsylvania HB 1695: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Status: Referred to Judiciary (as of 2023-10-03)

State: Pennsylvania · Session: 2023-2024 · Bill: HB 1695

Sponsors: Doyle Heffley, Jamie Flick, R. Lee James

View Pennsylvania HB 1695 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.